Evidence map›Paper›PMID 39878104›Full record

ReviewCurrent drug targets2025

From Structure to Function: Isatin Derivatives as a Promising Class of Antiviral Agents.

Anshul Jamwal, Shagun Sharma, Vijay Kumar Kapoor, Raveen Chauhan, Kamal Dua, Vikrant Dalwal, Akshay Kumar, Parteek Prasher, Poonam Negi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current drug targets, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anshul JamwalSchool of Pharmaceutical Sciences, Shoolini University, Solan, HP, India.ORCID 0009-0000-4708-8861
Shagun SharmaSchool of Pharmaceutical Sciences, Shoolini University, Solan, HP, India.
Vijay Kumar KapoorSchool of Pharmaceutical Sciences, Shoolini University, Solan, HP, India.
Raveen ChauhanSchool of Pharmaceutical Sciences, Shoolini University, Solan, HP, India.ORCID 0000-0002-4485-5081
Kamal DuaDiscipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia.
Vikrant DalwalDepartment of Pharmaceutical Chemistry, Gautam College of Pharmacy, Hamirpur HP, India.
Akshay KumarDepartment of Pharmaceutical Chemistry, Gautam College of Pharmacy, Hamirpur HP, India.
Parteek PrasherDepartment of Chemistry, University of Petroleum and Energy Studies, Dehradun, Uttarakhand, India.
Poonam NegiSchool of Pharmaceutical Sciences, Shoolini University, Solan, HP, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A range of heterocyclic compounds, including Isatin (oneH-indole-2, 3-dione) and its by-products, have been shown to represent potential unit blocks in the synthesis of potential medicinal agents. Numerous studies have been carried out on isatin, its synthesis, biological uses, and its chemical composition since when it was discovered. Functionally, these isatin-containing heterocycles have demonstrated antibacterial, antidiabetic, antiviral, antitubercular, and anticancer properties, among many others.

Indexed as

Antiviral AgentsIsatinDrug DevelopmentMolecular StructureStructure-Activity RelationshipAntiviral AgentsIsatinantiviralIsatinisatin hybridsN-Mannich bases.SARS-CoV-2structure activity relationship

Identifiers

PMID39878104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.